What are the symptoms of bipolar disorder and what strategies can be used to de‑escalate acute manic or mixed episodes?

Bipolar Disorder Symptoms and De-escalation Strategies

For acute manic or mixed episodes, immediately initiate pharmacotherapy with lithium, valproate, or atypical antipsychotics (aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone), with benzodiazepines for acute agitation and sleep disturbance, while avoiding antidepressant monotherapy which can precipitate or worsen mania. 1

Core Symptoms of Bipolar Disorder

Manic Episodes

• Elevated or irritable mood lasting at least one week
• Grandiosity (inflated self-esteem or unrealistic beliefs about abilities)
• Decreased need for sleep (feeling rested after only 3 hours)
• Pressured speech (talking more than usual, difficult to interrupt)
• Flight of ideas or racing thoughts
• Distractibility (attention easily drawn to irrelevant stimuli)
• Increased goal-directed activity or psychomotor agitation
• Excessive involvement in high-risk activities (spending sprees, sexual indiscretions, foolish investments)

Mixed Episodes

Mixed presentations combine manic symptoms with ≥3 depressive symptoms occurring simultaneously, including:

• Depressed mood
• Anxiety
• Anhedonia
• Guilt or worthlessness
• Suicidal ideation

Critical caveat: Mixed episodes carry higher suicide risk, more severe symptoms, worse prognosis, and greater treatment resistance compared to pure mania 2, 3. These patients require more aggressive intervention.

Immediate De-escalation Strategies for Acute Episodes

Pharmacological Intervention (Primary Treatment)

First-line agents - Choose based on severity and presentation 1, 4:

For mild-to-moderate mania or mixed episodes:

• Valproate (divalproex sodium)
• Olanzapine
• Aripiprazole

For severe mania or mixed episodes with psychotic features:

• Combination therapy: Valproate or lithium PLUS an atypical antipsychotic (olanzapine, risperidone, quetiapine, aripiprazole, or ziprasidone) 2

For acute agitation and sleep disturbance:

• Benzodiazepines as adjunctive therapy 1
• Warning: May cause disinhibition in younger children

Medication Selection Algorithm

1. Assess severity: Mild vs. severe symptoms, presence of psychosis
2. Check for rapid cycling: If present, favor valproate over lithium
3. Evaluate psychotic symptoms: If present, atypical antipsychotic is essential
4. Consider patient/family history: Prior medication response in patient or parents predicts current response 1
5. Review side effect profile: Weight gain concerns (olanzapine, quetiapine), metabolic issues, patient preferences

Critical Actions to Avoid

Discontinue antidepressants immediately during manic or mixed episodes 2:

• Antidepressants can destabilize mood and precipitate or worsen mania
• A manic episode triggered by antidepressants is classified as substance-induced per DSM criteria 1
• Never use antidepressants as monotherapy in bipolar disorder 3

Avoid gabapentin and topiramate - controlled studies show no efficacy for acute mania 1

Evidence-Based Treatment Hierarchy

Strongest Evidence for Acute Mania/Mixed Episodes

Atypical antipsychotics with robust data 5, 4, 6:

• Aripiprazole
• Asenapine
• Olanzapine
• Risperidone
• Ziprasidone
• Cariprazine (newer agent with positive data)

Mood stabilizers 4, 6:

• Valproate/divalproex: Strong evidence for mixed episodes
• Carbamazepine: Effective but second-line
• Lithium: Efficacy questionable in mixed episodes despite being effective in pure mania 6

Combination Therapy Considerations

When to combine 2:

• Severe episodes requiring rapid control
• Inadequate response to monotherapy after 1-2 weeks
• Mixed episodes (typically require combination)
• Psychotic features present

Effective combinations:

• Mood stabilizer (lithium or valproate) + atypical antipsychotic
• This increases efficacy and reduces time to remission 6, 2

Special Populations and Situations

Children and Adolescents

• Lithium is FDA-approved down to age 12 for acute mania and maintenance 1
• Most other agents used off-label based on adult data
• Exercise extreme caution in preschool children - diagnostic validity not established 1
• Address environmental, developmental, and temperamental factors before aggressive pharmacotherapy 1

High-Risk Features Requiring Immediate Attention

• Suicidality: Annual suicide rate 0.9% in bipolar disorder vs. 0.014% in general population; 15-20% lifetime suicide completion rate 3
• Substance abuse: High comorbidity rates requiring concurrent assessment 1
• Psychotic symptoms: Mandate antipsychotic inclusion in regimen

Adjunctive and Maintenance Considerations

Psychosocial Interventions

While pharmacotherapy is primary for acute episodes, family-focused treatment (FFT-A) shows efficacy for:

• Reducing manic symptom severity long-term
• Improving family cohesion and relationships
• Decreasing expressed emotion in families 7

Maintenance After Acute Stabilization

• Continue antipsychotic for at least 4 weeks in combination with mood stabilizer to prevent early relapse 1
• Olanzapine and quetiapine have strongest maintenance data 4
• Lamotrigine for preventing depressive relapse (not acute treatment) 4

Common Pitfalls to Avoid

1. Misdiagnosing mixed episodes as pure depression and treating with antidepressants alone - this worsens outcomes
2. Premature discontinuation of antipsychotics after acute stabilization - high relapse rates occur 1
3. Polypharmacy without justification - use combinations strategically, not reflexively 1
4. Ignoring metabolic monitoring - bipolar patients have 37% metabolic syndrome prevalence, 21% obesity, contributing to 12-14 year reduced life expectancy 3
5. Overlooking medication adherence - over 50% of patients are non-adherent 3